Literature DB >> 8811371

No increase in cyclosporin neurotoxicity in transplant recipients treated with liposomal amphotericin B.

O Ringdén, E E Andström, M Remberger, B M Svahn, J Tollemar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8811371     DOI： 10.1007/bf01781112

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

Review 1.  Cyclosporine in allogeneic bone marrow transplantation.

Authors:  O Ringdén
Journal:  Transplantation       Date:  1986-11       Impact factor: 4.939

2.  Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation.

Authors:  C H June; C B Thompson; M S Kennedy; J Nims; E D Thomas
Journal:  Transplantation       Date:  1985-06       Impact factor: 4.939

3.  Is cyclosporin neurotoxicity enhanced in the presence of liposomal amphotericin B?

Authors:  M E Ellis; D Spence; P Ernst; F Meunier
Journal:  J Infect       Date:  1994-07       Impact factor: 6.072

4.  Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.

Authors:  O Ringdén; E Andström; M Remberger; B M Svahn; J Tollemar
Journal:  Bone Marrow Transplant       Date:  1994       Impact factor: 5.483

5.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.